Clinical Trial Update: Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

The document reports an early-phase (Phase 1/2) study evaluating MPC-6827 in combination with carboplatin for recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• MPC-6827

Snippet

Sponsor: Myrexis Inc. | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: UNKNOWN